This article is more than 5 years old. Information may no longer be current.
Addario Lung Cancer Foundation presents lectureship award
Click Here to Manage Email Alerts
The Addario Lung Cancer Foundation presented this year’s Addario Foundation Lectureship Award to Fred R. Hirsch, MD, PhD, CEO of the International Association for the Study of Lung Cancer.
Hirsch received the award at this year’s International Lung Cancer Congress.
Fred R. Hirsch
“Dr. Hirsch’s contribution and dedication to lung cancer research is truly remarkable,” Bonnie J. Addario, a lung cancer survivor and founder of the Addario Lung Cancer Foundation, said in a press release. “We are thrilled to present him with the eighth Addario Lectureship Award to highlight his commitment to eliminating lung cancer worldwide.”
Hirsch, a professor at University of Colorado, was chosen as this year’s award recipient because of his lifetime contribution to lung cancer research, as well as his engagement in promoting international collaborations in lung cancer research and education.
Hirsch focuses on the development and validation of biomarkers for early detection of lung cancer, as well as on new targeted therapies. He most recently served as co-principal investigator for the clinical development of necitumumab (Lilly), a monoclonal antibody intended for patients with squamous lung cancer.
“No one has devoted more time to [the International Association for the Study of Lung Cancer] and to global scientific and educational lung cancer activities than Dr. Hirsch,” Paul A. Bunn Jr., MD, distinguished professor at University of Colorado and previous CEO of the association, said in the press release.
David R. Gandara, MD, co-chair of the International Lung Cancer Congress and chair of the SWOG Lung Committee, said he could not think of a more deserving award recipient.
“Dr. Hirsch embodies all the characteristics of a translational scientist,” Gandara said in the press release. “Plus, he possesses a rare leadership quality that facilitates bringing groups of investigators from diverse backgrounds together to form highly productive collaborative research teams.”